Dr Michelle Magid, Dr Jason Reichenberg and Tyler Willenbrink discuss the use of botulinum toxin A in the treatment of depression Depression is the leading cause of disability worldwide and is a major contributor to the overall burden of disease, …
To access this post, you must purchase Aesthetics Journal Subscriptions – AJ Print & Digital Subscriber, Aesthetics Journal Subscriptions – AJ Digital Subscriber or Aesthetics Journal Subscriptions – AJ News Subscriber.
log in
log in
